Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 18:6:105-12.
doi: 10.2147/PGPM.S50598. eCollection 2013.

Delivering pharmacogenetic testing in a primary care setting

Rachel Mills  1 , Deepak Voora, Bruce Peyser, Susanne B Haga
Affiliations

Delivering pharmacogenetic testing in a primary care setting

Rachel Mills et al. Pharmgenomics Pers Med. .

Abstract

Pharmacogenetic testing refers to a type of genetic test to predict a patient's likelihood to experience an adverse event or not respond to a given drug. Despite revision to several labels of commonly prescribed drugs regarding the impact of genetic variation, the use of this testing has been limited in many settings due to a number of factors. In the primary care setting, the limited office time as well as the limited knowledge and experience of primary care practitioners have likely attributed to the slow uptake of pharmacogenetic testing. This paper provides talking points for primary care physicians to discuss with patients when pharmacogenetic testing is warranted. As patients and physicians become more familiar and accepting of pharmacogenetic testing, it is anticipated that discussion time will be comparable to that of other clinical tests.

Keywords: patient education; pharmacogenetic testing; pharmacogenetics; primary care.

PubMed Disclaimer

References

    1. PharmGKB: Simvastatin [homepage on the Internet] Stanford, CA: The Pharmacogenomics Knowledgebase; c2001–2013[updated July 1, 2013]. Available from: http://pharmgkb.org/drug/PA451363Accessed July 24, 2013
    1. Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. N Engl J Med. 2011;364(12):1144–1153. - PMC - PubMed
    1. Manolio TA, Chisholm RL, Ozenberger B, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15(4):258–267. - PMC - PubMed
    1. CDC/NCHS National Ambulatory Medical Care Survey: 2010 Summary Tables Atlanta, GA: Centers for Disease Control and Prevention; 2010Available from: http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdfAccessed August 1, 2013
    1. Frueh FW, Amur S, Mummaneni P, et al. Pharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: prevalence of related drug use. Pharmacotherapy. 2008;28(8):992–998. - PubMed